By Pulse8
Payers stratify premiums for a given benefits package by the member s relationship to the policy holder, and if permitted, by age or gender. This stratification discourages enrolling higher-risk, hence unprofitable, members. Risk-adjustment (RA) aligns premiums with the cost of caring for members with documented conditions, removing that incentive and encouraging the enrollment of higher risk members.¹ The magnitude of these adjustments can be thousands of dollars per member each year and can easily exceed the typical profit margin of plans.¹ Therefore, complete, accurate and ongoing sizing of these opportunities drive the payer s strategy.² ³
Gaps are closed by confirming each member s open conditions from claims or reviews of medical records, which can be expensive. However, confirmations supply needed revenues for their care, and sophisticated risk-adjustment analytics can identify undiagnosed conditions for earlier, more effective care.² ³ Let s examine
FRPS
rps.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rps.org Daily Mail and Mail on Sunday newspapers.
Jazz Pharmaceuticals Announces FDA Approval of Additional Indication for Vyxeos® (daunorubicin and cytarabine) for the Treatment of Secondary Acute Myeloid Leukemia in Pediatric Patients
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Jazz Pharmaceuticals Announces FDA Approval of Additional Indication for Vyxeos® (daunorubicin and cytarabine) for the Treatment of Secondary Acute Myeloid Leukemia in Pediatric Patients
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.